Vimpat
Vimpat is a medication primarily used for the treatment of epilepsy. Its active ingredient, Lacosamide, works by stabilizing electrical activity in the brain, thereby reducing seizure frequency. Available in tablet form, Vimpat offers a convenient oral administration route for patients. It is typically prescribed as part of a comprehensive epilepsy management plan. Vimpat is suitable for adults and adolescents over the age of 16. Regular monitoring and dosage adjustments may be necessary to achieve optimal therapeutic outcomes. It is essential to follow the prescribed regimen for effective seizure control.Active substance:
LacosamidePharmachologic effect:
Vimpat is an antiepileptic drug that works by stabilizing hyperexcitable neuronal membranes and inhibiting repetitive neuronal firing.Indications:
- Partial-onset seizures in patients aged 4 years and older
- Adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older
Contraindications:
- Hypersensitivity to lacosamide or any of the excipients
- Severe cardiac conduction disorders such as second or third-degree AV block
Side effects:
In order of decreasing probability: Dizziness, Headache, Nausea, Diplopia, Fatigue, Ataxia, Tremor, Vomiting, Vertigo, Depression
Dosing and Administration:
The recommended starting dose is 50 mg twice daily, which can be increased to a maintenance dose of 100 mg to 200 mg twice daily, based on individual patient response and tolerability. Dose adjustments may be necessary for patients with renal or hepatic impairment.
Storage:
Store at a temperature not exceeding 25°C (77°F).
